1. Home
  2. PHVS vs CCEC Comparison

PHVS vs CCEC Comparison

Compare PHVS & CCEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • CCEC
  • Stock Information
  • Founded
  • PHVS 2015
  • CCEC 2007
  • Country
  • PHVS Netherlands
  • CCEC Greece
  • Employees
  • PHVS N/A
  • CCEC N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • CCEC Marine Transportation
  • Sector
  • PHVS Health Care
  • CCEC Consumer Discretionary
  • Exchange
  • PHVS Nasdaq
  • CCEC Nasdaq
  • Market Cap
  • PHVS 1.0B
  • CCEC 1.1B
  • IPO Year
  • PHVS 2021
  • CCEC 2007
  • Fundamental
  • Price
  • PHVS $22.29
  • CCEC $18.27
  • Analyst Decision
  • PHVS Buy
  • CCEC Buy
  • Analyst Count
  • PHVS 6
  • CCEC 1
  • Target Price
  • PHVS $35.67
  • CCEC $22.00
  • AVG Volume (30 Days)
  • PHVS 67.6K
  • CCEC 18.9K
  • Earning Date
  • PHVS 11-13-2024
  • CCEC 11-08-2024
  • Dividend Yield
  • PHVS N/A
  • CCEC 3.28%
  • EPS Growth
  • PHVS N/A
  • CCEC N/A
  • EPS
  • PHVS N/A
  • CCEC 0.85
  • Revenue
  • PHVS N/A
  • CCEC $447,305,000.00
  • Revenue This Year
  • PHVS N/A
  • CCEC N/A
  • Revenue Next Year
  • PHVS N/A
  • CCEC N/A
  • P/E Ratio
  • PHVS N/A
  • CCEC $74.04
  • Revenue Growth
  • PHVS N/A
  • CCEC 29.66
  • 52 Week Low
  • PHVS $15.37
  • CCEC $13.10
  • 52 Week High
  • PHVS $33.00
  • CCEC $20.26
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 54.95
  • CCEC N/A
  • Support Level
  • PHVS $18.81
  • CCEC N/A
  • Resistance Level
  • PHVS $21.85
  • CCEC N/A
  • Average True Range (ATR)
  • PHVS 1.44
  • CCEC 0.00
  • MACD
  • PHVS -0.17
  • CCEC 0.00
  • Stochastic Oscillator
  • PHVS 52.81
  • CCEC 0.00

About PHVS Pharvaris N.V.

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .

About CCEC Capital Clean Energy Carriers Corp. Common Share

Capital Clean Energy Carriers Corp is an international shipping company. It is the leading platform of gas carriage solutions with a focus on the energy transition. The company owns 20 high-specification vessels, including 12 latest-generation LNG carriers (LNG/Cs) and eight legacy Neo-Panamax container vessels.

Share on Social Networks: